Literature DB >> 15830491

Growth inhibition of enteric bacteria by Vibrio cholerae in nutrient media containing lactate, acetate, or citrate.

K Bhaskaran, S S Iyer, A W Khan, V C Vora.   

Abstract

In cross-streak tests on nutrient agar containing lactate, acetate, or citrate, the growth of certain enteric bacteria was inhibited by themselves or by Vibrio cholerae, or by both. This mimicked the activity of bacteriocins, but the phenomenon was attributable to the accumulation of carbonate and increased alkalinity of the media.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15830491      PMCID: PMC444655          DOI: 10.1128/AAC.6.3.375

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  VIBRIO CHOLERAE AND COLICINES.

Authors:  D BARUA
Journal:  Nature       Date:  1963-11-16       Impact factor: 49.962

2.  Lethal biosynthesis of a new antibacterial principle: vibriocin.

Authors:  H FARKAS-HIMSLEY; P L SEYFRIED
Journal:  Nature       Date:  1962-03-24       Impact factor: 49.962

3.  A method for typing Shigella sonnei, using colicine production as a marker.

Authors:  J D ABBOTT; R SHANNON
Journal:  J Clin Pathol       Date:  1958-01       Impact factor: 3.411

4.  BACTERIOCINS AND BACTERIOCIN-LIKE SUBSTANCES.

Authors:  G Ivanovics
Journal:  Bacteriol Rev       Date:  1962-06

Review 5.  Colicins and related bacteriocins.

Authors:  M Nomura
Journal:  Annu Rev Microbiol       Date:  1967       Impact factor: 15.500

6.  Vibriocine production in the cholera and El Tor vibrios.

Authors:  A H Wahba
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

7.  Bacteriocin Typing of Vibrio cholerae.

Authors:  A N Chakrabarty; S Adhya; J Basu; S G Dastidar
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

  7 in total
  1 in total

1.  Single bacteriocin typing scheme for the vibrio group of organisms.

Authors:  S Mitra; T S Balganesh; S G Dastidar; A N Chakrabarty
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.